January 2018 CURRICULUM VITAE AGNES B. KANE PERSONAL DATA Business Address: Department of Pathology and Laboratory Medicine, Brown University, Box G-E534, Providence, Rhode Island 02912 Business Telephone Number: (401) 863-1110 Fax: (40l) 863-9008 EDUCATION B.A. Swarthmore College, Zoology 1968 M.D. Temple University School of Medicine 1974 Ph.D. Temple University School of Medicine, Experimental Pathology 1976 PROFESSIONAL APPOINTMENTS 1996-2017 Chair, Department of Pathology & Laboratory Medicine, Brown University, Providence, RI 1995-present Professor, Department of Pathology & Laboratory Medicine, Brown University, Providence, RI 1992-present Director, Training Program in Environmental Pathology, Brown University, Providence, RI 1987-95 Associate Professor, Department of Pathology & Laboratory Medicine, Brown University, Providence, RI 1982-87 Assistant Professor, Department of Pathology & Laboratory Medicine, Brown University, Providence, RI 1979-82 Staff Pathologist, Temple University Hospital, Philadelphia, PA 1977-82 Assistant Professor, Department of Pathology and Fels Research Institute, Temple University School of Medicine, Philadelphia, PA 1977-78 Resident in Anatomic Pathology, Temple University Hospital 1976-77 Postdoctoral Fellowship, National Research Service Award under Dr. Nils R. Ringertz, Medical Cell Genetics, Karolinska Institute, Stockholm, Sweden 1975-76 Resident in Anatomic Pathology, Temple University Hospital SPECIALTY BOARD CERTIFICATION 1979 Anatomic Pathology PROFESSIONAL LICENSES Pennsylvania, Rhode Island (inactive) HONO RS AN D AWA RDS Graduated with Distinction, Swarthmore College, 1968 Phi Beta Kappa, 1968; Sigma Xi Research Society, 1968 General Motors Scholarship, Swarthmore College, 1965-68 University Fellow of Temple University, 1971-73 Lucretia Mott Graduate Fellowship, 1969-71 Research Career Development Award, National Institutes of Health, 1981-86 Distinguished Teaching Award, Brown University Medical School Graduating Class, 1986, 1987 Mary Putnam-Jacobi Award, Brown University Women in Medicine, 1986 Senior Citation, Brown University Medical School Graduating Class, 1988 Honorary Citation, Brown University Association of Women Medical Faculty and the Office of Women in Medicine, 1996 Burroughs Welcome Visiting Professorship in the Basic Medical Sciences, 1998 Temple University School of Medicine Alumni Achievement Award, 1999 Dean’s Excellence in Teaching Award, Brown Medical School, 2001, 2003- 2010 De Trana Endowed Lectureship in Pathology, University of Illinois Medical School, 2004 Brown University and Women & Infants’ Hospital National Center of Excellence in Women’s Health, Outstanding Faculty Mentor Award, 2008 Fellow, American Association for the Advancement of Science, 2011 Certificate of Recognition for Exemplary Teaching in General Pathology, 2016 PROFESSIONAL SOCIETIES American Society for Investigative Pathology: Women's Committee (1987-93); Chair (1990-93) Program Committee (1990-96); Meritorious Awards Committee (1996); Council (1997-00); Publications Committee (1997-00) FASEB Women's Excellence in Science Award Committee (1991-93) FASEB Experimental Biology Cell Injury Theme Committee: Chair (1991-93) International Academy of Pathology American Association for the Advancement of Science Rhode Island Society of Pathologists American Chemical Society OTHER PROFESSIONAL ACTIVITIES 1982-85 Member of the editorial board of Cell Biology International Reports 1982-present Reviewer for Experimental Cell Research, Laboratory Investigation, Journal of Cellular Physiology, American Journal of Pathology, Science, The FASEB Journal, Cancer Research, American Journal of Respiratory Cell and Molecular Biology, Experimental Lung Research, Toxicology Applied Pharmacology, Environmental Health Perspectives, Chemical Research in Toxicology 1984 Member of Task Force III for National Institute of Environmental Health Sciences: Molecular and Cellular Mechanisms of Environmental Injury 1984-88 Member of Medical Research Service Merit Review Board for Basic Sciences: Veterans Administration 1988-92 Environmental Health Sciences Review Committee, National Institute of Environmental Health Sciences 1991 Organizer and Moderator for the Workshop on Grantsmanship in Competitive Times sponsored by the AAP Women's Committee at the Annual Meeting of FASEB in Atlanta, GA on April 24, 1991 2 1990-91 Org anizing Commi ttee for the Wo rkshop on App roaches to Eva luating Toxicity and Carcinogenicity of Man-Made Fibers held in Durham, NC on November 11-13, 1991 1991 Panelist for the Academic Advancement Breakfast, Association of Women Medical Faculty, Brown University 1991 Moderator for Women's Health Care Issues Discussed by Women Researchers, Women in Medicine, Brown University 1991, 1994 Ad Hoc Reviewer, Health Effects Institute 1992 Organizer and Moderator for the Workshop on Combining Research and Practice in Pathology, sponsored by the AAP Women's Committee at the Annual Meeting of FASEB in Anaheim, CA on April 8, 1992 1992-96 Associate Editor, The American Journal of Pathology 1992, 1994 Ad Hoc Reviewer, American Cancer Society, Carcinogenesis and Nutrition Study Section 1992 Invited Participant in the Workshop on Women in Biomedical Careers: Dynamics of Change sponsored by the Office of Research on Women's Health, National Institutes of Health in Bethesda, MD on June 11-12, 1992 1993-95 Research Review Committee, Bureau of Mines 1993 Organizer for the Workshop on Research Opportunities in Women's Health, sponsored by the ASIP Women's Committee at the Annual Meeting of FASEB in New Orleans, LA on March 31, 1993 1993 Organizer and Moderator for the Faculty Development Workshop for Women Medical Faculty, Residents and Fellows sponsored by the Office for Women in Medicine and the Association of Women Medical Faculty, Brown University 1993 Ad Hoc Member, Task Force on Medical Schools, American Association of University Professors 1993-96 Mine Health Research Advisory Committee, National Institute for Occupational Safety and Health 1994 Invited Participant in a Workshop on International Cooperative Research on the Assessment of Toxicology of Man Made Fibers sponsored by the French Ministries of Health, Labor, Environmental and Industry in Paris, France on September 14, 1994 1995 Scientific Advisor to the International Agency for Research on Cancer, World Health Organization, Lyon, France: January 1-20 and March 5-April 5, 1995 1995 Lecturer on Cell Injury in Pathobiology for Basic Scientists sponsored by the American Society for Investigative Pathology in Atlanta, GA on April 9, 1995 1996-99 External Review Committee for the Environmental Health Science Center, 3 Uni versity o f Roch ester, Ja nuary 2 2-23, 1 996 and April 21-22, 1 999 1996 Co-Chair with Dr. Rudolpho Saracci: Workshop on Mechanisms of Mineral Fiber Carcinogenesis, International Agency for Research on Cancer, World Health Organization, Lyon, France, January 9-11, 1996 1996 Vice-Chair, IARC Working Group on Silica, Some Silicates, Coal Dust and para-Aramid Fibrils, International Agency for Research on Cancer, World Health Organization, Lyon, France, October 15-22, 1996 1996-04 Member of the editorial board of Toxicology and Applied Pharmacology, The American Journal of Pathology 1997 Invited Participant in a Workshop on Non-Animal Tests for Evaluation of the Toxicity of Solid Xenobiotics sponsored by the JRC Environment Institute of the European Commission in Angera, Italy on October 23-31, 1997. 1998 Chair, Symposium on Molecular Genetics and Gene Therapy of Human Malignant Mesothelioma at the 87th Annual Meeting of the United States and Canadian Academy of Pathology in Boston, March 1, 1998 1998 Guest Speaker and Judge for Student Awards at the First Annual Laboratory Medicine and Pathobiology Research Day, University of Toronto, Canada, March 18, 1998 1998 Invited Participant in a Workshop on Relevance of the Rat Lung Response to Particle Overload for Human Risk Assessment sponsored by the International Life Sciences Institute, Washington, DC, March 23-24, 1998 1998-99 Invited Participant, Subcommittee on Manufactured Vitreous Fibers, Committee on Toxicology, National Academy of Sciences/National Research Council 1999 Invited Participant, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, vol. 74: Foreign Bodies, Surgical Implants and Prosthetic Devices, International Agency for Research on Cancer, World Health Organization, Lyon, France, February 2-March 2, 1999 1999 Invited Participant, MMMF Conference, Vienna, Austria, June 9-11, 1999 2000 Chair, NIOSH Review Committee on Effects of Mixed Dusts on Pulmonary Inflammation, Airway Reactivity and Susceptibility of Pulmonary Infection, Alexandria, VA, July 26, 2000 2001 Chair, IARC Working Group on Man-Made Vitreous Fibres, Vol. 81, International Agency for Research on Cancer, World Health Organization, Lyon, France, October 8-16, 2001 2002 Invited Speaker, New Directions and Needs in Asbestos Research, National Institute of Environmental Health Sciences, University of Montana – Missoula, MT, June 24-25, 2002. 4 2002 Co-Chair, Plenary Session 1: How does a mesothelial cell become cancerous? 6th Meeting of the International Mesothelioma Interest Group, Perth, Western Australia, December 1-4, 2002 2003 Invited Participant, Workshop on Genetically Modified Rodent Models for Cancer Hazard Identification, National Toxicology Program, Washington, DC, February 21, 2003 2003 Invited Participant, Working Group on Testing of Fibrous Particles: Short-term Assays, ILSI Risk Science Institute and U.S. Environmental Protection Agency, Washington, DC, March 6-7, 2003. 2004-10 Member of the editorial board of Laboratory Investigation 2003-07 Member of the Environmental Health Sciences Review Committee, National Institute of Environmental Health Sciences 2004 External Reviewer, Graduate Program in Laboratory Medicine and Pathobiology, University of Toronto, Canada, April 29-30, 2004 2004 Invited Participant, Developmental Approaches for Evaluation of Toxicological Interactions of Nanoscale Materials, US EPA, NTP, NIOSH, NSF, Gainesville, FL, November 2-4, 2004. 2005 Guest editor, Carbon. 2005-present Member of the editorial board of The International Journal of Nanomedicine. 2005 Phase I and Phase II Reviewer for Superfund Basic Research Program Grants, October 17-20, 2005. 2005-06 Member, Committee on Asbestos: Selected Health Effects, Institute of Medicine. 2006-12 Member of the U.S. Environmental Protection Agency Science Advisory Board. 2007-08 Chair, IARC Working Group on Burden of Cancer Caused by Asbestos, World Health Organization. 2007 Invited Participant, International Council on Nanotechnology (ICON) Panel to establish priorities for nanotechnology research, Zurich, Switzerland, June 5-7, 2007. 2006 NanoBusiness Alliance Public Policy Tour, Washington, D.C., January 30-31, 2007. 2008 Co-Chair and Organizer, Symposium on Environmental and Human Health Impacts of Nanomaterials, 236th National Meeting of the American chemical Society, Philadelphia, Pennsylvania, August 20, 2008. 5 2008-present Member of the editorial board of Particle Fibre Toxicology. 2008-present Member of the editorial board of Chemical Research in Toxicology. 2008 Invited Speaker, Symposium on Present and Future Directions in Nanotechnology, AAAS Annual Meeting, Chicago, February 12-16, 2009. 2009 Member, Workshop on Asbestos MOA, NIEHS, North Carolina, December 16- 17, 2009. 2010 Invited Speaker and Session Chair, International Conference on Biomedical and Environmental Sciences & Technology, Beijing, China, May 9-12, 2010. 2011 Invited Participant, Gordon Research Conference on Environmental Nanotechnology, Waterville Valley, NH, May 29- June 3, 2011. 2011 Invited Participant, NSF Workshop on Nanomaterials and the Environment: The Chemistry and Materials Perspective, Arlington, VA, June 27-29, 2011. 2011 Invited Participant, Nano Carb11: Carbon Nanotubes and Related Materials- From Physico-Chemical Properties to Biological and Environmental Effects, Acquafredda di Maratea, Italy, September 6-11, 2011. 2011 Invited Speaker and Session Chair, Libby Amphibole Research Symposium, October 13-15, 2011. 2012 Chair, Peer Review of Draft IRIS Assessment of Libby Amphibole Asbestos, U.S. EPA. 2012 Invited Speaker, Environmental Health and Technology, STEM Symposium for Underrepresented Minority Students, University of Pennsylvania, October 12- 13, 2012. 2013 External Advisory Committee, UCLA Center for Environmental Implications of Nanomaterials. 2013-16 Invited Participant, UCLA-CEIN Workshop on Alternative Testing Strategies for Carbon Nanotubers, January 16-17, 2013. 2014 Keynote Speaker, International Conference on Monitoring and Surveillance of Asbestos-Related Diseases 2014, Finnish Institute of Occupational Health, Helsinki, Finland, February 11-13, 2014. 2014 Invited Participant, Categorization Strategies for Engineered Nanomaterials in a Regulatory Context, Woodrow Wilson Center, Washington, D.C., May 19-20, 2014. 2014 Oil Spill Science Seminar for Journalists, Metcalf Institute for Marine and Environmental Reporting, January 27-29, 2014 6 2014 Keynote Speaker, International Conference on Monitoring and Surveillance of Asbestos-Related Disease 2014, Finnish Institute of Occupational Health, Helsinki, Finland, February 11-13, 2014 2014 Invited Participant, Categorization Strategies for Engineered Nanomaterials in a Regulatory Context, Woodrow Wilson Center, Washington, D.C., May 19-20, 2014 2014 Instructor on Environmental Health and Safety of Engineered Nanomaterials at an Eagleson Institute Occupational Health Colloquium, Providence, R.I., June 8-9, 2014 2014 Chair, International Agency for Research on Cancer, World Health Organization, Evaluation of the Carcinogenicity of Fluoro-edenite Asbestos, Silicon Carbide Fibers and Whiskers, and Carbon Nanotubes, Lyon, France, September 30-October 7, 2014 2014 Invited Speaker and Participant, National Science Foundation, Workshop on NanoEHS: Fundamental Science Needs, Boston, M.A., November 1, 2014 2016 Invited Speaker, Nanomat 2-D Materials Workshop, Dubendorf, Switzerland, March 21-23, 2016 2017 Invited Speakers, The Monticello Conference on Elongated Mineral Particles, Monticello, Virginia, October 16-20, 2017. UNIVERSITY ACTIVITIES Freshman Academic Advisor (1983-85) Medical Admissions Committee (1982-85) M.D.-Ph.D. Program, Co-Director (1988-89) Committee on the Status of Women (1983-85) Reviewer for ACS Institutional Grant (1983-90) Faculty Advisor for Women in Medicine (1983-present) Summer Research Assistantship Committee (1986) R.I. - Brown Science Collaborative (1985-86) Co-Founder of the Association of Women Medical Faculty of Brown University (1986); Faculty Coordinator (1986-93) Chair, Admissions Committee for the Graduate Program in Molecular Biology, Cell Biology and Biochemistry (1986-87) Committee on Faculty Reappointment and Tenure (1987-89) Affirmative Action Monitoring Committee (1991-92) Member of the Board of Environmental Studies (1991-97) Steering Committee, Postdoctoral Research Training Program in Pathophysiology of Pulmonary Disease (1988-94) Search Committee for the Dean of Medicine and Biological Sciences (1991-92) Medical School Curriculum Committee (1991-93) Program Director, Training Grant in Environmental Pathology (NIH T32 ES 07272, 1992-present) Chair, Medical School Mission Statement Committee (1994) Steering Committee, M.D., Ph.D. Program (1994-present) Wriston Grant Selection Committee (1994) Campus Advisory Committee, Search for the President of Brown University (1997) Faculty Seminar: The Scholarship of Teaching, Sheridan Center (1999) 7 Adviso ry Boa rd: Offi ce of W omen i n Medic ine (20 03-pres ent) Translational Research Committee, RIH COBRE Center for Cancer Research Development (2003 –2007) Research Advisory Board, Brown University (2004-2008) Brown – Lifespan Oncology Council (2008 – 2009) Leader, Nanohealth Working Group for Institute for Molecular and Nanoscale Innovation Director, Training Core for Superfund Research Program (2005-present) Co-Director, GAANN Training Grant: Interdisciplinary Training in Applications and Implications of Nanotechnology, Department of Education (2009-present) Member, Search Committee for Chair of Obstetrics and Gynecology (2012) Member, Strategic Planning Committee on Re-imagining the Brown Campus (2012-2013) Strategic Planning Partner, School of Public Health (2014) IBES Faculty Fellow and Leader, Human Health and Wellbeing Theme (2015 – present) COMMUNITY SERVICE Scientific Consultant for the Rhode Island Commission for Safety and Occupational Health (1986-present) Commission to Identify Occupational Diseases which Pose a Major Health Threat to Workers in Rhode Island (1987-90) PUBLICATIONS 1. Kane A, Basilico C and Baserga R: Transcriptional activity and chromatin structural changes in a temperature-sensitive mutant of BHK cells blocked in early G . Exp. Cell Res. 94 165- 1 173 (1976). 2. Rossini M, Kane A and Baserga R: Nuclear control of cell proliferation pp 177-190 In: Drewinko B. and Humphrey RG eds., Growth Kinetics and Biochemical Regulation of Normal and Malignant Cells. Williams and Wilkins Co., Baltimore, 1977. 3. Ringertz NR, Bols N, Ege T, Kane A, Krondahl U, Linder S and Shelton K: Reconstruction of viable cells from cell fragments, pp 444-488, In: Brinkley BR and Porter KR eds., International Cell Biology 1976-1977, Rockefeller University Press, New York, 1977. 4. Bols NC, Kane AB and Ringertz NR: Restoration of metabolic cooperation in heterokaryons between HGPRT-deficient mouse A9 fibroblasts and chick embryo erythrocytes. Somatic Cell Genetics 5: 1045-1059 (1979). 5. Schanne FAX, Kane AB, Young EE and Farber JL: Calcium dependence of toxic liver cell death: A final common pathway. Science 206: 700-702 (1979). 6. Kane AB and Bols NC: A study of metabolic cooperation with rat peritoneal macrophages. J. Cell. Physiol. 102: 385-393 (1980). 7. Kane AB, Young EE, Schanne FAX and Farber JL: Calcium dependence of phalloidin- induced liver cell death. Proc. Natl. Acad. Sci., USA 77: 1177-1180 (1980). 8 8. Ka ne AB, Stanton RP, R aymond EG, D obson M E, Kn afelc M E and F arber JL : Dissociation of intracellular lysosomal rupture from the cell death due to silica. J. Cell Biology 87: 643- 651 (1980). 9. Russo MA, Kane AB and Farber JL: Ultrastructural pathology of phalloidin-intoxicated hepatocytes in the presence or absence of extra-cellular calcium. Am. J. Path. 109: 133-144 (1982). 10. Abrams WR, Diamond LW and Kane AB: A flow cytometric assay of neutrophil degranulation. J. Histochem. Cytochem. 31: 737-744 (1983). 11. Idell S, Meltzer M, Knafelc E, Kane A, Meyers AR and Berney S: Primary systemic amyloidosis with a retroperitoneal mass. Clin. Exp. Rheum. 2: 181-184 (1984). 12. Kane AB, Petrovitch DR, Stern RO and Farber JL: ATP depletion and the loss of cell integrity in anoxic hepatocytes and silica-treated P388D macrophages. Am. J. Physiol 249: 1 C256-C266 (1985). 13. Macdonald JL and Kane AB: Identification of asbestos fibers within single cells. Lab. Invest. 55: 177-185 (1986). 14. Goodglick LA and Kane AB: The role of reactive oxygen metabolites in crocidolite asbestos toxicity to macrophages. Cancer Res. 46: 5558-5566 (1986). 15. Moalli PA, Macdonald JL, Goodglick LA and Kane AB: Acute injury and regeneration of the mesothelium in response to asbestos fibers. Am. J. Path. 128: 426-445 (1987). 16. Dobson ME, Stern RO and Kane AB: Selective purine release from P388D macrophages 1 injured by silica. J. Cell Physiol. 135: 244-252 (1988). 17. Branchaud RM, Macdonald JL and Kane AB: Induction of angiogenesis by intraperitoneal injection of asbestos fibers. The FASEB J. 3: 1747-1752 (1989). 18. Goodglick LA, Pietras LA and Kane AB: Evaluation of the causal relationship between crocidolite asbestos-induced lipid peroxidation and toxicity to macrophages. Am. Rev. Resp. Dis. 139: 1265-1273 (1989). 19. Gleva GF, Goodglick LA and Kane AB: Altered calcium homeostasis in irreversibly-injured P388D macrophages. Am. J. Path. 137: 43-58 (1990). 1 20. Goodglick LA and Kane AB: Cytotoxicity of long and short crocidolite asbestos fibers in vitro and in vivo. Cancer Res. 50: 5153-5163 (1990). 21. McClellan RO, Miller FJ, Hesterberg TN, Warheit DB, Bunn WB, Dement JM, Kane AB, Lippman M, Mast RW, McConnell EE and Reinhardt CF: Approaches to evaluating the toxicity and carcinogenicity of man-made fibers. Regulatory Toxicology and Pharmacology 16: 321-364 (1992). 22. Macdonald JL and Kane AB: Regulation of mesothelial cell proliferation by the extracellular matrix in vivo. Eur. Resp. Rev. 3: 123-125 (1993). 23. Cora EM and Kane AB: Alterations in a tumor suppressor gene, p53, in mouse mesotheliomas induced by crocidolite asbestos. Eur. Resp. Rev. 3: 148-150 (1993). 9 24. Br anchau d RM, G arant L J and K ane A B: Path ogenesi s of me sothelia l reactio ns to asbestos fibers: monocyte recruitment and macrophage activation. Pathobiology 61: 154-163 (1993). 25. Moyer VD, Cistulli CA, Vaslet CA and Kane AB: Oxygen radicals and asbestos carcinogenesis. Environmental Health Persp. 102:131-136 (1994). 26. Cistulli CA, Sorger T, Marsella JM, Vaslet CA and Kane AB: Spontaneous p53 mutation in murine mesothelial cells: increased sensitivity to DNA damage induced by asbestos and ionizing radiation. Toxicol. Appl. Pharmacol. 141:264-271 (1996). 27. Marsella JM, Liu BL, Vaslet CA and Kane AB, Susceptibility of p53-deficient mice to induction of mesothelioma by crocidolite asbestos fibers. Environ. Health Persp. 105:1069-1072 (1997). 28. Goodglick LA, Vaslet CA, Messier NJ and Kane AB, Growth factor responses and protooncogene expression of murine mesothelial cell lines. Toxicologic Pathology 25:565-573 (1997). 29. Macdonald JL and Kane AB: Mesothelial cell proliferation and biopersistence of wollastonite and crocidolite asbestos fibers. Fundam. Appl. Toxicol. 38:173-183 (1997). 30. Yano N, Endoh M, Fadden K, Yamashita H, Kane A, Sakai H and Rifai A: Comprehensive gene expression profile of the adult human renal cortex: Analysis by cDNA array hybridization. Kidney International 57:1452-1459 (2000). 31. Yano N, Habib NA, Fadden KJ, Yamashita H, Mitry R, Jauregui H, Kane A, Endoh M and Rifai A: Profiling the adult human liver transcriptome: Analysis by cDNA array hybridization. J Hepatology 35:178-186 (2001). 32. Vaslet CA, Messier NJ and Kane AB: Accelerated progression of asbestos-induced mesotheliomas in heterozygous p53+/- mice. Toxicol Sciences 68:331-338 (2002). 33. Kellerman LC, Valeyrie L, Fernandez N, Opolon P, Sabourin J-C, Maube E, LeRoy P, Kane AB, Legrand A, Abina MA, Descamps V and Haddada H: Regression of AK7 malignant mesothelioma established in immunocompetent mice following intratumoral gene transfer of interferon gamma. Cancer Gene Therapy 10:481-490 (2003). 34. Yuan ZL, Guan YJ, Wang LJ, Wei W, Kane AB and Chin YE: Central role of the threonine residue within the p+1 loop of receptor tyrosine kinase in STAT3 constitutive phosphorylation in metastatic cancer cells. Mol Cell Biol 24: 9390-9400 (2004). 35. Altomare DA, Ramos-Nino ME, Xiao G-H, Wang HQ, Skele KL, DeRienzo AD, Mossman BT, Kane AB and Testa JR: The AKT/PKB pathway is frequently activated in human murine mesotheliomas and can be targeted to inhibit mesothelioma cell growth. Oncogene 24: 6080-6089 (2005). 36. Altomare DA, Vaslet CA, Skele KL, DeRienzo A, Devarajan K, Jhanwar SC, McClatchey AI, Kane AB and Testa JR: A mouse model recapitulating molecular features of human mesothelioma. Cancer Res 65:8090-8095 (2005). 37. Kane AB: Animal models of malignant mesothelioma. Inhalation Toxicol. 18: 1001-1004 (2006). 38. Hurt RH, Monthioux M and Kane A: Toxicology of carbon nanomaterials: Status, trends, and perspectives on the special issue. Carbon 44:1028-1033 (2006). 10